Education Programme

Programme

The programme will focus on speakers and companies that are in the process of implementation and transitioning to automation with specific focus on the barriers, development, security, workforce changes and challenges.

  • Plant Tours
  • Social Events

Track 1A - Automation Industry 4.0

Track Leaders:
Hans Heesakkers, Managing Director, Circuition Life Science Consultants
Abdelghani Meqdad, MEA Global Sales and Projects Manager, Veolia Water Technologies, YP ISPE
France

Track 2A - Analytics & Predictive Control

Track Leaders:
Heike Roeder, Head of Process & Knowledge Management, Bayer AG
Oliver Ingold, Anlage-Ingenieur, Lonza, YP ISPE DACH

Track 1B - Vertical & Horisontal End-to-End Integration

Track Leaders:
Lorenz Binggelli, QM-IT, B. Braun Medical AG
Juan José Alba Gil, Altran, YP ISPE Spain

Track 2B - Workforce 4.0

Track Leaders:
Hans Martin Schwarm, Health Care Consultant
Federico Poli, YP ISPE Italy

Programme Schedule

  • Thursday, 23 November
    0800 - 0900 Welcome Coffee
    0900 - 0915 Welcome
    Chair:
    Christian Woelbeling, Senior Director Global Accounts, WERUM IT Solutions
    Co-Chair: Teresa Minero, LifeBee Founder & CEO - President ISPE Italy, Hosting Affiliate - Chair ISPE European Affiliate Council
    0915 - 0935 Pharma 4.0 Survey Results: What Does Pharma Industry Understand Under Industry 4.0?
    Impact Analysis and Maturity Modeling

    Teresa Minero, LifeBee Founder & CEO - President ISPE Italy - Chair ISPE European Affiliate Council
    Hanns Erle, Senior Advisor to the Pharmaceutical Industry, former EVP Global Manufacturing & Supply, Merck Serono SA
    0935 - 0955 From Industry 4.0 to Pharma 4.0 - the ISPE Special Interest Group's Approach
    Christian Woelbeling, Senior Director Global Accounts, WERUM IT Solutions
    0955 - 1015 Pharma 4.0 – High level Impact and Maturity Approach
    Uli Kuchenbrod, Innovation Management, Vetter Pharma Fertigung GmbH & Co. KG
    1015 - 1035 The Role Of an ICH Based Holistic Manufacturing Control Strategy
    Christian Woelbeling, Senior Director Global Accounts, WERUM IT Solutions
    1035 - 1115 Networking Break in the Exhibition Area
    1115 - 1155 Industry 4.0 and The Digital Enterprise - Input From Non-Pharma Branches
    Alastair Orchard, VP Digital Enterprise, Siemens PLM Software
    1155 - 1230 Lean Experience Factory in Venice: Case Study for Industry 4.0
    Rainer Ulrich, Senior Expert, McKinsey & Company
    Daniele Iacovelli, Leader Digital & Advanced Analytics, McKinsey & Company
    1230 - 1240 Presentation by Zambon
    Santo Carbone, Site Director Vicenza Plant, Zambon Group
    1240 - 1400 Networking Lunch in the Exhibition Area
    1400 - 1430 (Track 1A) Augmented Reality in Real Shop Floor Automation
    Dirk Schrader, Executive VP, Head of Global Technical Operations, Vifor Pharma AG
    1400 - 1430 (Track 2A) Proactively Leading Quality Performance Improvement: Understanding the Impact of Culture and the Importance of an Overall System Perspective
    Nuala Calnan, Senior Associate, Lachman Consultants
    1430 - 1500 (Track 1A) e-Medication in the Clinical Supply Chain
    Hans Heesakkers, Managing Director, Circuition Life Science Consultants
    1430 - 1500 (Track 2A) Pharma Integrated Predictive Quality: Real-Time Release
    Francesco Minà, Director, Solids and Packaging, Execution Systems COE, Janssen, Pharmaceutical Companies of Johnson and Johnson
    1500 - 1430 (Track 1A) Digitalisation in Pharma - Industry Case Studies
    Andrew Whytock, Global Business and Solution Development/Pharma & Life
    Sciences, Siemens
    1500 - 1430 (Track 2A) From R&D To Manufacturing - Full Information Transparency and Integrity Unleashes Efficiencies
    Matthias Arnold, Consultant Digital Solutions Strategy, Eppendorf AG
    1530 - 1630 Networking Break in the Exhibition Area
    1630 - 1700 (Track 1A) Hospital Intra-Logistic Improvement Using Autonomous Intelligent Vehicles
    Bruno Adam, European General Manager, Omron Mobile Robotics
    1630 - 1700 (Track 2A) Predictive Control Based on Big Data Analytics: A Project within a Smart Factory 4.0 Programme in a Medical Device Company
    Stefano Gelsomini, Operations Director, Livanova
    1700 - 1730 (Track 1A) The New Automation Paradigm To Prepare Pharma 4.0  
    Alessandro Ferroni, Engineering Director, Dompé farmaceutici S.p.A.
    1700 - 1730 (Track 1A) Quality Moving to the GxP Regulated Cloud
    Robert Gaertner, Director Europe Strategy, Veeva Vault QualityDocs
    1730 - 1800 (Joint Session) Global Harmonised Manufacturing Processes Enables Digitalisation In Pharma Manufacturing Operations
    Clemens Hohfelser, NTO Global Manufacturing Execution Process Owner, Novartis
    1800 - 1815 Closing Remarks
    All speakers
    1815 - 1900 Welcome Reception
    1930 - 2230 Networking Dinner
  • Friday, 24 November
    0830 - 0900 (Track 1B) A Journey Towards Pharma 4.0
    Lorenz Binggeli, QM-IT, B. Braun Medical AG
    0830 - 0900 (Track 2B) Workforce 4.0 - What Does Pharma 4.0 Need on Expert and Management Levels?
    Margit Schwalbe-Fehl, Managing Partner, Baipharma
    0900 - 0930 (Track 1B) The Integrated Shopfloor (Plug and Produce, ISPE Special Interest Group Pharma 4.0)
    Klaus Sauermann, Business Development Manager, Werum IT Solutions GmbH
    0900 - 0930 (Track 2B) Future Industry Picture - People in a Fully Automated World
    Young Professionals WORKSHOP
    0930 - 1015 Networking Break in the Exhibition Area
    1015 - 1045 (Track 1B) The Manufacturing Control Strategy - How It Links to Pharma 4.0 and Enables Smarter Project and Operational Execution
    Line Lundsberg-Nielsen, Global Technology Partner, NNE
    1015 - 1045 (Track 2B) New Expertise and New Education In The World Of Industry 4.0
    Giambattista Gruosso, Professor, Politecnico of Milan
    1045 - 1115 (Track 1B) Excellence Initiative - How a Group of Pharma Machine Suppliers Adapt Automation
    Kathrin Günther, Team Leader Sales Support Software & Automation, Uhlmann Pac Systems
    1045 - 1115 (Track 2B) Applied Knowledge Management
    Michelangelo Canzoneri, Head of Technology and Innovation Therapeutic Proteins, Sanofi
    1115 - 1145 (Track 1B) Cyber Security Risks Implied by Industry 4.0
    Enzo M. Tieghi, CEO, ServiTecno
    1115 - 1145 (Track 2B) Lilly's Roadmap On Pharma 4.0
    Gian Mauro Brozzi, Manufacturing & Quality IT Director, Eli Lilly and Company - Italy
    1145 - 1200 Short Networking Break
    1200 - 1230 (Joint Session) Final Panel Discussion: Perspective On Pharma 4.0, "Data Integrity By Design" As a Premise For Pharma 4.0 Track Leaders
    1230 - 1330 Networking Lunch in the Exhibition Area
    1330 - 1700 Site Visits at Manufacturers:
    Zambon - Vicenza, secondary pharmaceutical plant, visit to the “Health & Quality Factory of Vicenza”: Zambon is a modern multinational pharmaceutical and fine-chemical group founded on the heritage and values of an innovative Italian family-owned enterprise that over the years has earned a strong reputation for high quality products and services. Zambon is headquartered in Milan and was established in 1906 in Vicenza. Zambon is present in 19 countries with subsidiaries in 5 continents and 2,800 employees. In 2016 revenues amounted to 713 million euro with 600 million euro sales from the pharmaceutical business. Zambon is well-established in 3 therapeutic areas: respiratory, pain and women’s health, and is committed to developing medicines to make patients’ lives better in specialty areas and rare disease such as Parkinson’s disease and cystic fibrosis. The group is active throughout the drug production chain with Zach - Zambon Chemicals for API (active ingredients), generics and custom products with €147 million sales in 2016 and manufacturing units in Italy, Switzerland, France, China and Brazil. ZCube, the research venture of the Zambon Group, supports and invests in innovative ideas in the fields of drug delivery, medical devices and digital health from early stages up to market launch. In 2016 ZCube launched the first made-in-Italy fast track acceleration program dedicated to projects in the life sciences. The Group provides also patient support programs (PSPs) through Italiassistenza, the first nationwide qualified healthcare and homecare network for the elderly and the disabled and disabled. Zambon products are commercialized in 84 countries.

    Estimated travel time 45’ from the conference site.

    FIS - Montecchio Maggiore: F.I.S. – Fabbrica Italiana Sintetici is a private Italian company that specialises in API production. Custom Synthesis is our core business, which means the exclusive production of intermediates, advanced intermediates and APIs for pharmaceutical companies who will own the NDA. F.I.S. has the capability to provide a wide array of integrated services to the customer, including process research and development, optimization, and scale-up facilities to support both validation and commercial launch. F.I.S. also develops and sells a wide range of Generic APIs including anxiolytics, anticonvulsants, antidepressants, analgesics, anti- inflammatory agents, antibacterials, antifungals, cardiovascular drugs, and diuretics.

    Estimated travel time 40’ from the conference venue.

Programme Changes

Last minute changes due to functional, private, or organisational needs can be necessary.  The event organiser accepts no liability for any additional costs caused by a change of programme. Programme is subject to change.